Ambarella Inc: Form 10-Q for the period ended Jul 31, 2024
Filed with the SEC on Sep 4, 2024 and accepted by EDGAR at Sep 4, 2024, 13:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-05-01 to 2024-07-31 | $63.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-02-01 to 2024-07-31 | $118.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-05-01 to 2024-07-31 | $25.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2024-02-01 to 2024-07-31 | $46.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-05-01 to 2024-07-31 | $38.7m | us-gaap:GrossProfit |
| Gross profit | 6 months2024-02-01 to 2024-07-31 | $71.9m | us-gaap:GrossProfit |
| Research and development | 3 months2024-05-01 to 2024-07-31 | $56.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-02-01 to 2024-07-31 | $110.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-05-01 to 2024-07-31 | $18.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2024-02-01 to 2024-07-31 | $36.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-05-01 to 2024-07-31 | −$36.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-02-01 to 2024-07-31 | −$75.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-05-01 to 2024-07-31 | $747.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-02-01 to 2024-07-31 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-05-01 to 2024-07-31 | −$34.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-02-01 to 2024-07-31 | −$72.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-05-01 to 2024-07-31 | −$0.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-02-01 to 2024-07-31 | −$1.78 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-05-01 to 2024-07-31 | −$0.85 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-02-01 to 2024-07-31 | −$1.78 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-05-01 to 2024-07-31 | 41,129,754 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-02-01 to 2024-07-31 | 40,952,373 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-02-01 to 2024-07-31 | $1.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-02-01 to 2024-07-31 | $3.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2024-07-31 | $153.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-07-31 | $279.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-07-31 | $650.3m | us-gaap:Assets |
| Current liabilities | At period end2024-07-31 | $91.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-07-31 | $102.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-07-31 | $547.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-103199. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.